PCN44 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SPAIN

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71940-4
https://www.valueinhealthjournal.com/article/S1098-3015(11)71940-4/fulltext
Title : PCN44 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SPAIN
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71940-4&doi=10.1016/S1098-3015(11)71940-4
First page : A259
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 101
Categories :
Tags :
Regions :
ViH Article Tags :